A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 353 participants.

Also called NCT01252056

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 353 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01252056
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01252056. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2012-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy
Condition
Diabetic Nephropathy
Intervention (Drug)
Probucol
Intervention (Drug)
Probucol and Cilostazol
Lead sponsor
Otsuka Beijing Research Institute (class: industry)

Record details

Record id
cardio:ct-nct01252056
Content hash
9db5237f971255fc8fad4a59654ee35a138ddea0bf364ed3475624386d631797